4453 Total Publications
Obesity impacts brain metabolism and structure independently of amyloid and tau pathology in healthy elderly
Pegueroles, J, Pané, A, Vilaplana, E, Montal, V, Bejanin, A, Videla, L, Carmona-Iragui, M, Barroeta, I, Ibarzabal, A, Casajoana, A, Alcolea, D, Valldeneu, S, Altuna, M, de Hollanda, A, Vidal, J, Ortega, E, Osorio, R, Convit, A, Blesa, R, Lleó, A, Fortea, J and Jiménez, A
2020; Journal Alzheimers Dement (Amst); vol. 12; no. 1; pp. e12052;
CSF glucose tracks regional tau progression based on Alzheimer's disease risk factors
Pappas, C, Klinedinst, BS, Le, S, Wang, Q, Larsen, B, McLimans, K, Lockhart, SN, Allenspach-Jorn, K, Mochel, JP, Willette, AA and Initiative, ftAsDN
2020; Journal Alzheimer's & Dementia: Translational Research & Clinical Interventions; vol. 6; no. 1; pp. e12080;
Clinical meaningfulness of subtle cognitive decline on longitudinal testing in preclinical AD
Papp, KV, Buckley, R, Mormino, E, Maruff, P, Villemagne, VL, Masters, CL, Johnson, KA, Rentz, DM, Sperling, RA, Amariglio, RE, Harvard Aging, B, Alzheimer's, D and Australian, I
2020; Journal Alzheimers & Dementia; vol. 16; no. 3; pp. 552-560;
Hippocampal neuroimaging‐informed clinical trial enrichment tool for amnestic mild cognitive impairment using open data
Conrado, DJ, Burton, J, Hill, D, Willis, B, Sinha, V, Stone, J, Coello, N, Wang, W, Chen, D and Nicholas, T
2020; Journal Clinical Pharmacology & Therapeutics;
Cerebrospinal fluid α-synuclein predicts neurodegeneration and clinical progression in non-demented elders
Li, JQ, Bi, YL, Shen, XN, Wang, HF, Xu, W, Tan, CC, Dong, Q, Wang, YJ, Tan, L and Yu, JT
PMCID:7685645
; 2020; Journal Transl Neurodegener; vol. 9; no. 1; pp. 41;
AD-NET: Age-adjust neural network for improved MCI to AD conversion prediction
Gao, F, Yoon, H, Xu, YZ, Goradia, D, Luo, J, Wu, T, Su, Y and Alzheimers Dis Neuroimaging, I
2020; Journal Neuroimage-Clinical; vol. 27;